» Articles » PMID: 31211814

Systems Analysis of Subjects Acutely Infected with the Chikungunya Virus

Abstract

The largest ever recorded epidemic of the Chikungunya virus (CHIKV) broke out in 2004 and affected four continents. Acute symptomatic infections are typically associated with the onset of fever and often debilitating polyarthralgia/polyarthritis. In this study, a systems biology approach was adopted to analyze the blood transcriptomes of adults acutely infected with the CHIKV. Gene signatures that were associated with viral RNA levels and the onset of symptoms were identified. Among these genes, the putative role of the Eukaryotic Initiation Factor (eIF) family genes and apolipoprotein B mRNA editing catalytic polypeptide-like (APOBEC3A) in the CHIKV replication process were displayed. We further compared these signatures with signatures induced by the Dengue virus infection and rheumatoid arthritis. Finally, we demonstrated that the CHIKV in vitro infection of murine bone marrow-derived macrophages induced IL-1 beta production in a mechanism that is significantly dependent on the inflammasome NLRP3 activation. The observations provided valuable insights into virus-host interactions during the acute phase and can be instrumental in the investigation of new and effective therapeutic interventions.

Citing Articles

Transcriptomic insights into early mechanisms underlying post-chikungunya chronic inflammatory joint disease.

Ramundo M, da Fonseca G, Ten-Caten F, Gerber A, Guimaraes A, Manuli E Sci Rep. 2025; 15(1):6745.

PMID: 40000671 PMC: 11861634. DOI: 10.1038/s41598-025-86761-x.


Early transcriptomic changes at the skin interface during Powassan virus transmission by ticks.

Paine D, Hermance M, Thangamani S Front Immunol. 2025; 15:1511132.

PMID: 39872517 PMC: 11769802. DOI: 10.3389/fimmu.2024.1511132.


International multi-cohort analysis identifies novel framework for quantifying immune dysregulation in critical illness: results of the SUBSPACE consortium.

Moore A, Zheng H, Ganesan A, Hasin-Brumshtein Y, Maddali M, Levitt J bioRxiv. 2024; .

PMID: 39605502 PMC: 11601436. DOI: 10.1101/2024.11.12.623298.


Unraveling the Complexity of Chikungunya Virus Infection Immunological and Genetic Insights in Acute and Chronic Patients.

Fritsch H, Giovanetti M, Clemente L, da Rocha Fernandes G, Fonseca V, de Lima M Genes (Basel). 2024; 15(11).

PMID: 39596565 PMC: 11593632. DOI: 10.3390/genes15111365.


Chikungunya-Driven Gene Expression Linked to Osteoclast Survival and Chronic Arthralgia.

Urbanski A, Maso V, Martins F, da Costa-Martins A, do Nascimento Oliveira A, Nakaya H Infect Dis Rep. 2024; 16(5):914-922.

PMID: 39311214 PMC: 11417755. DOI: 10.3390/idr16050073.


References
1.
Liao Y, Smyth G, Shi W . featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2013; 30(7):923-30. DOI: 10.1093/bioinformatics/btt656. View

2.
Schwartz O, Albert M . Biology and pathogenesis of chikungunya virus. Nat Rev Microbiol. 2010; 8(7):491-500. DOI: 10.1038/nrmicro2368. View

3.
Tan Y, Pickett B, Shrivastava S, Gresh L, Balmaseda A, Amedeo P . Differing epidemiological dynamics of Chikungunya virus in the Americas during the 2014-2015 epidemic. PLoS Negl Trop Dis. 2018; 12(7):e0006670. PMC: 6085065. DOI: 10.1371/journal.pntd.0006670. View

4.
Chang A, Martins K, Encinales L, Reid S, Acuna M, Encinales C . Chikungunya Arthritis Mechanisms in the Americas: A Cross-Sectional Analysis of Chikungunya Arthritis Patients Twenty-Two Months After Infection Demonstrating No Detectable Viral Persistence in Synovial Fluid. Arthritis Rheumatol. 2017; 70(4):585-593. PMC: 8127625. DOI: 10.1002/art.40383. View

5.
Kirschfink M, Nurnberger W . C1 inhibitor in anti-inflammatory therapy: from animal experiment to clinical application. Mol Immunol. 1999; 36(4-5):225-32. DOI: 10.1016/s0161-5890(99)00048-6. View